391 related articles for article (PubMed ID: 12033947)
1. Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1.
Pepinsky RB; Mumford RA; Chen LL; Leone D; Amo SE; Riper GV; Whitty A; Dolinski B; Lobb RR; Dean DC; Chang LL; Raab CE; Si Q; Hagmann WK; Lingham RB
Biochemistry; 2002 Jun; 41(22):7125-41. PubMed ID: 12033947
[TBL] [Abstract][Full Text] [Related]
2. Effect of divalent cations on the affinity and selectivity of alpha4 integrins towards the integrin ligands vascular cell adhesion molecule-1 and mucosal addressin cell adhesion molecule-1: Ca2+ activation of integrin alpha4beta1 confers a distinct ligand specificity.
Day ES; Osborn L; Whitty A
Cell Commun Adhes; 2002; 9(4):205-19. PubMed ID: 12699089
[TBL] [Abstract][Full Text] [Related]
3. Multiple activation states of integrin alpha4beta1 detected through their different affinities for a small molecule ligand.
Chen LL; Whitty A; Lobb RR; Adams SP; Pepinsky RB
J Biol Chem; 1999 May; 274(19):13167-75. PubMed ID: 10224072
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin.
Marcinkiewicz C; Taooka Y; Yokosaki Y; Calvete JJ; Marcinkiewicz MM; Lobb RR; Niewiarowski S; Sheppard D
J Biol Chem; 2000 Oct; 275(41):31930-7. PubMed ID: 10926928
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin is a ligand for the alpha4beta1 integrin.
Bayless KJ; Meininger GA; Scholtz JM; Davis GE
J Cell Sci; 1998 May; 111 ( Pt 9)():1165-74. PubMed ID: 9547293
[TBL] [Abstract][Full Text] [Related]
6. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.
Lin Kc; Ateeq HS; Hsiung SH; Chong LT; Zimmerman CN; Castro A; Lee WC; Hammond CE; Kalkunte S; Chen LL; Pepinsky RB; Leone DR; Sprague AG; Abraham WM; Gill A; Lobb RR; Adams SP
J Med Chem; 1999 Mar; 42(5):920-34. PubMed ID: 10072689
[TBL] [Abstract][Full Text] [Related]
7. A small molecule alpha4beta1/alpha4beta7 antagonist differentiates between the low-affinity states of alpha4beta1 and alpha4beta7: characterization of divalent cation dependence.
Egger LA; Cao J; McCallum C; Kidambi U; Van Riper G; McCauley E; Mumford RA; Lanza TJ; Lin LS; de Laszlo SE; Young DN; Yang G; Dean DC; Raab CE; Wallace MA; Jones AN; Hagmann WK; Schmidt JA; Pepinsky RB; Scott DM; Lee WC; Cornebise MA; Detmers PA
J Pharmacol Exp Ther; 2003 Sep; 306(3):903-13. PubMed ID: 12766251
[TBL] [Abstract][Full Text] [Related]
8. Evidence that ligand and metal ion binding to integrin alpha 4beta 1 are regulated through a coupled equilibrium.
Chen LL; Whitty A; Scott D; Lee WC; Cornebise M; Adams SP; Petter RC; Lobb RR; Pepinsky RB
J Biol Chem; 2001 Sep; 276(39):36520-9. PubMed ID: 11473127
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrins.
Moyano JV; Carnemolla B; Domínguez-Jiménez C; García-Gila M; Albar JP; Sánchez-Aparicio P; Leprini A; Querzé G; Zardi L; Garcia-Pardo A
J Biol Chem; 1997 Oct; 272(40):24832-6. PubMed ID: 9312081
[TBL] [Abstract][Full Text] [Related]
10. Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin alpha4beta1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes.
Newham P; Craig SE; Clark K; Mould AP; Humphries MJ
J Immunol; 1998 May; 160(9):4508-17. PubMed ID: 9574557
[TBL] [Abstract][Full Text] [Related]
11. Divalent cations and ligands induce conformational changes that are highly divergent among beta1 integrins.
Bazzoni G; Ma L; Blue ML; Hemler ME
J Biol Chem; 1998 Mar; 273(12):6670-8. PubMed ID: 9506964
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and binding properties of a fluorescent α₉β₁/α₄β₁ integrin antagonist and its application as an in vivo probe for bone marrow haemopoietic stem cells.
Cao B; Hutt OE; Zhang Z; Li S; Heazlewood SY; Williams B; Smith JA; Haylock DN; Savage GP; Nilsson SK
Org Biomol Chem; 2014 Feb; 12(6):965-78. PubMed ID: 24363056
[TBL] [Abstract][Full Text] [Related]
13. ADAM disintegrin-like domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7.
Bridges LC; Sheppard D; Bowditch RD
Biochem J; 2005 Apr; 387(Pt 1):101-8. PubMed ID: 15504110
[TBL] [Abstract][Full Text] [Related]
14. Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters alpha4beta1- and alpha5beta1-mediated function.
Porter JC; Hogg N
J Cell Biol; 1997 Sep; 138(6):1437-47. PubMed ID: 9298996
[TBL] [Abstract][Full Text] [Related]
15. Functional relevance during lymphocyte migration and cellular localization of activated beta1 integrins.
Gómez M; Luque A; del Pozo MA; Hogg N; Sánchez-Madrid F; Cabañas C
Eur J Immunol; 1997 Jan; 27(1):8-16. PubMed ID: 9021992
[TBL] [Abstract][Full Text] [Related]
16. The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1.
Morris GE; Denniff MJ; Karamanavi E; Andrews SA; Kostogrys RB; Bountziouka V; Ghaderi-Najafabadi M; Shamkhi N; McConnell G; Kaiser MA; Carleton L; Schofield C; Kessler T; Rainbow RD; Samani NJ; Webb TR
Br J Pharmacol; 2022 Nov; 179(21):4958-4973. PubMed ID: 35802072
[TBL] [Abstract][Full Text] [Related]
17. Alpha4beta1-integrin activation is necessary for high-efficiency T-cell subset interactions with VCAM-1 under flow.
Lim YC; Wakelin MW; Henault L; Goetz DJ; Yednock T; Cabañas C; Sánchez-Madrid F; Lichtman AH; Luscinskas FW
Microcirculation; 2000 Jun; 7(3):201-14. PubMed ID: 10901499
[TBL] [Abstract][Full Text] [Related]
18. Activation status and function of the VLA-4 (alpha4beta1) integrin expressed on human melanoma cell lines.
Saini A; Seller Z; Davies D; Marshall JF; Hart IR
Int J Cancer; 1997 Oct; 73(2):264-70. PubMed ID: 9335453
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary eosinophilia in a murine model of allergic inflammation is attenuated by small molecule alpha4beta1 antagonists.
Kudlacz E; Whitney C; Andresen C; Duplantier A; Beckius G; Chupak L; Klein A; Kraus K; Milici A
J Pharmacol Exp Ther; 2002 May; 301(2):747-52. PubMed ID: 11961081
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the alpha4beta1 integrin-osteopontin interaction.
Barry ST; Ludbrook SB; Murrison E; Horgan CM
Exp Cell Res; 2000 Aug; 258(2):342-51. PubMed ID: 10896785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
